IMCR
Immunocore Holdings Ltd
29.70$
-2.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -271.6% | – | – | -10.0% | -166.0% | – | +5,868.7% | -117.2% | – | – | – | – | |
| – | -89.3% | +561.0% | -1.8% | +4.2% | +12.7% | -26.8% | -8.7% | +2.3% | +4.5% | +13.5% | +8.6% | – | |
| – | +86.5% | -41.4% | +11.6% | -34.4% | +32.1% | +9.5% | +5.7% | -2.0% | -15.2% | -24.4% | +149.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -195.7% | – | +234.6% | -229.8% | – | – | – | -105.0% | – | – | – | – | |
| – | -6.2% | -23.6% | -22.9% | +149.8% | +332.9% | -91.7% | +38.9% | +80.7% | +285.0% | -38.3% | -55.6% | – | |
| – | – | -170.9% | +81,397.9% | -99.8% | +327.5% | – | -413.5% | – | -116.8% | – | -118.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -27.0% | +6,381.6% | -100.1% | – | -26,115.7% | – | +43.9% | -49.2% | +129.6% | -84.7% | +2,317.3% | – | |
| – | -117.1% | – | -184.0% | – | -350.2% | – | -47.5% | -5.5% | -393.0% | – | – | – | |
| – | -293.7% | – | – | -12.3% | -186.4% | – | +18,549.6% | -120.4% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.